Table I.
Demographic Characteristics of the Study Participants
| Number of patients | 203 |
|---|---|
| Number of hips | 203 |
| Male, female (number of patients) | 34, 169 |
| Age, years (mean±SD, range) | 65.3±10.9, 37-90 |
| Height, cm (mean±SD, range) | 153±9.7, 118-179 |
| Weight, kg (mean±SD, range) | 57.3±11.8, 28.7-100 |
| BMI, kg/m2 (mean±SD, range) | 24.3±4.1, 16-43 |
| Diagnosis (number of patients, (male, female)) | |
| Developmental dysplasia of the hip | 185 (25,160) |
| Osteonecrosis | 7 (6,1) |
| Trauma | 3 (2,1) |
| Rheumatoid arthritis | 3 (0,3) |
| Rapidly destructive coxarthropathy | 3 (0,3) |
| Perthes disease | 2 (1,1) |
| Pre-operative NSAIDs use (number of patients, (%)) | 55 (27%) |
| Pre-operative ACEI/ARB use (number of patients, (%)) | 48 (24%) |
| Pre-operative diuretic use (number of patients, (%)) | 8 (3.9%) |
| Pre-operative statin use (number of patients, (%)) | 39 (19%) |
| History of diabetes mellitus (number of patients, (%)) | 20 (10%) |
| Anaesthetic type | |
| Spinal (number of patients, (%)) | 195 (96%) |
| General (number of patients, (%)) | 8 (4%) |
| Operation time (min) | 49±19.0, 29-158 |
| Total blood loss (g) | 292±130.8, 14-704 |
*SD - standard deviation; BMI - body mass index; NSAIDs - nonsteroidal anti-inflammatory drugs; ACEI - angiotensin-converting enzyme inhibitor; ARB - angiotensin-II receptor blocker